Reverse Transcriptase Polymerase Chain Reaction < Rheumatic Diseases < Rheumatic Fever

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000096 (2020)	Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]	Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.
000324 (2019)	Piercarlo Sarzi-Puttini [Italie] ; Angela Ceribelli [Italie] ; Daniela Marotto [Italie] ; Alberto Batticciotto [Italie] ; Fabiola Atzeni [Italie]	Systemic rheumatic diseases: From biological agents to small molecules.
000384 (2019)	K. Brazdilova ; T. Koller ; Z. Killinger ; J. Payer	Prevalence and risk factors for drug-induced liver injury among patients with rheumatic diseases treated with biological therapy: a single-center experience.
000661 (2018)	Maria Gerosa [Italie] ; Lorenza Maria Argolini [Italie] ; Carolina Artusi [Italie] ; Cecilia Beatrice Chighizola [Italie]	The use of biologics and small molecules in pregnant patients with rheumatic diseases.
000720 (2018)	Martin J. Bergman [États-Unis]	Reply.
000744 (2018)	Surabhi S. Vinod [États-Unis] ; Annelle B. Reed [États-Unis] ; Jamelle Maxwell [États-Unis] ; Randy Q. Cron [États-Unis] ; Matthew L. Stoll [États-Unis]	Pediatric rheumatology infusion center: report on therapeutic protocols and infusions given over 4 Years with focus on adverse events over 1 Year.
000751 (2018)	Ju-Yang Jung [Corée du Sud] ; Moon-Young Kim [Corée du Sud] ; Chang-Hee Suh [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud]	Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review.
000781 (2018)	Joshua F. Baker [États-Unis] ; Michael D. George [États-Unis]	Is RAPID3 a Good Predictor of Radiographic Outcomes in Rheumatoid Arthritis? Comment on the Article by Khawaja et al.
000827 (2018)	Yasuaki Okuda [Japon] ; Toshiyuki Yamada [Japon] ; Mitsuharu Ueda [Japon] ; Yukio Ando [Japon]	First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan.
000A19 (2017)	Monika Stensen [Norvège]	The use of biologics in pregnant patients with rheumatic disease.
000A26 (2017)	Timothy Beukelman [États-Unis] ; Yukiko Kimura [États-Unis] ; Norman T. Ilowite [États-Unis] ; Kelly Mieszkalski [États-Unis] ; Marc D. Natter [États-Unis] ; Grendel Burrell [États-Unis] ; Brian Best [États-Unis] ; Jason Jones [États-Unis] ; Laura E. Schanberg [États-Unis]	The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.
000B14 (2017)	Raphaèle Seror [France] ; Xavier Mariette [France]	Malignancy and the Risks of Biologic Therapies: Current Status.
000B45 (2017)	Cong Tri Tran [France] ; Alexandra Ducancelle [France] ; Charles Masson [France] ; Françoise Lunel-Fabiani [France]	Herpes zoster: Risk and prevention during immunomodulating therapy.
000B46 (2017)	Christos Koutsianas [Royaume-Uni] ; Konstantinos Thomas [Grèce] ; Dimitrios Vassilopoulos [Grèce]	Hepatitis B Reactivation in Rheumatic Diseases: Screening and Prevention.
000C20 (2017)	Francisco Espinoza [Chili] ; Pierre Le Blay [Chili] ; Bernard Combe [Chili]	Biologic Disease-modifying Antirheumatic Drug (bDMARD)-induced Neutropenia: A Registry from a Retrospective Cohort of Patients with Rheumatic Diseases Treated with 3 Classes of Intravenous bDMARD.
000C22 (2017)	Jay Mehta [États-Unis] ; Timothy Beukelman [États-Unis]	Biologic Agents in the Treatment of Childhood-Onset Rheumatic Disease.
000C52 (2017)	C. Kneitz [Allemagne] ; J. Atta [Allemagne] ; H. Burkhardt [Allemagne]
000C55 (2016)	Jaume Alijotas-Reig [Espagne] ; Enrique Esteve-Valverde [Espagne] ; Raquel Ferrer-Oliveras [Espagne]	[Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease].
000D23 (2016)	Carina Götestam Skorpen [Norvège] ; Maria Hoeltzenbein [Allemagne] ; Angela Tincani [Italie] ; Rebecca Fischer-Betz [Allemagne] ; Elisabeth Elefant [France] ; Christina Chambers [États-Unis] ; Josè Da Silva [Portugal] ; Catherine Nelson-Piercy [Royaume-Uni] ; Irene Cetin [Italie] ; Nathalie Costedoat-Chalumeau [France] ; Radboud Dolhain [Pays-Bas] ; Frauke Förger [Suisse] ; Munther Khamashta [Royaume-Uni] ; Guillermo Ruiz-Irastorza [Espagne] ; Angela Zink [Allemagne] ; Jiri Vencovsky [République tchèque] ; Maurizio Cutolo [Italie] ; Nele Caeyers [Belgique] ; Claudia Zumbühl [Suisse] ; Monika Stensen [Norvège]	The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
000E86 (2016)	Roger A. Levy [Brésil] ; Guilherme R. De Jesús [Brésil] ; Nilson R. De Jesús [Brésil] ; Evandro M. Klumb [Brésil]	Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation.
000F24 (2016)	Sulaiman M. Al-Mayouf [Arabie saoudite] ; Abdullatif Alenazi [Arabie saoudite] ; Hind Aljasser [Arabie saoudite]	Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Rheumatic Diseases" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Rheumatic Diseases" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Rheumatic Diseases
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021